February 27, 2017 / 8:27 AM / 5 months ago

BRIEF-Recordati signs license agreement with the Meyer Hospital in Florence

1 Min Read

Feb 27 (Reuters) - Recordati Industria Chimica e Farmaceutica SpA:

* Signs an exclusive license agreement with the Meyer Hospital in Florence

* Agreement covers the know-how of the Meyer Hospital for the development of a treatment for pre-term babies affected by retinopathy of prematurity

* Treatment is currently being investigated in a phase II clinical trial by the Meyer Hospital

* Recordati will complete the clinical development and the regulatory steps necessary to obtain the marketing approval for the drug Source text: bit.ly/2ml9uJQ Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below